A patient with bladder cancer who started mirabegron twice daily a week ago now has polyuria; how should this be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 13, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended treatment and dosage for overactive bladder using Myrbetriq (mirabegron)?

At what time does Mirabegron (beta-3 adrenergic agonist) initiate its action in an adult patient with overactive bladder?

What is the recommended treatment regimen for overactive bladder using Mirabegron (beta-3 adrenergic agonist)?

What alternative medications, such as Myrbetriq (mirabegron), can be considered for a 57-year-old male with overactive bladder (OAB) symptoms, currently on Gemtesa (vibegron) and oxybutynin (oxybutynin chloride), with minimal improvement?

What is the best treatment option for a 68-year-old male with a history of nephrolithiasis (kidney stones) and symptoms of urinary frequency, urgency, and nocturia, who has previously shown improvement with Flomax (tamsulosin)?

In a 7‑year‑old boy with a closed, complete transverse proximal humeral fracture, can a sugar‑tong or U‑mold cast be used for immobilization?

For an elderly cataract surgery patient with a lidocaine toxicity/allergy, which amide local anesthetic—mepivacaine or bupivacaine—offers a safer peribulbar block?

In an adult patient under critical‑care monitoring, what does a mixed venous oxygen saturation of 66 % indicate?

What is the recommended dosing, contraindications, and monitoring for Mirabegron in adults with overactive bladder, including dose adjustments for renal or hepatic impairment and precautions in uncontrolled hypertension?

What is the appropriate dosing, contraindications, and precautions for repaglinide in an adult with type 2 diabetes?

How rare is chronic myelomonocytic leukemia (CMML) (a MDS/MPN)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.